Clinical trial registries and clinical trial result posting: new paradigm for medical writers.
暂无分享,去创建一个
[1] Unmasking ghost writers , 2001, Clinical pharmacology and therapeutics.
[2] M. Egger,et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis , 2004, The Lancet.
[3] Clinical trial registration: a statement from the International Committee of Medical Journal Editors , 2004, The Lancet.
[4] Kamran Abbasi,et al. Compulsory registration of clinical trials , 2004, BMJ : British Medical Journal.
[5] M. Foote. Guidelines and policies for medical writers in the biotech industry: an update on the controversy. , 2004, Biotechnology annual review.
[6] MaryAnn Foote,et al. Review of current authorship guidelines and the controversy regarding publication of clinical trial data. , 2003, Biotechnology annual review.
[7] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[8] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.
[9] D. Rennie,et al. Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin. , 1994, JAMA.
[10] R. Horton,et al. Sponsorship, authorship, and accountability. , 2001, Obstetrics and gynecology.